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Abstract
Background: Aerogels are a versatile group of nanostructured/nanoporous materials with physical and chemical properties
that can be adjusted to suit the application of interest. In terms of biomedical applications, aerogels are particularly suitable
for implants such as membranes, tissue growth scaffolds, and nerve regeneration and guidance inserts. The mesoporous
nature of aerogels can also be used for diffusion based release of drugs that are loaded during the drying stage of the
material. From the variety of aerogels polyurea crosslinked silica aerogels have the most potential for future biomedical
applications and are explored here.
Methodology: This study assessed the short and long term biocompatibility of polyurea crosslinked silica aerogel implants
in a Sprague-Dawley rat model. Implants were inserted at two different locations a) subcutaneously (SC), at the dorsum and
b) intramuscularly (IM), between the gluteus maximus and biceps femoris of the left hind extremity. Nearby muscle and
other internal organs were evaluated histologically for inflammation, tissue damage, fibrosis and movement (travel) of
implant.
Conclusion/Significance: In general polyurea crosslinked silica aerogel (PCSA) was well tolerated as a subcutaneous and an
intramuscular implant in the Sprague-Dawley rat with a maximum incubation time of twenty months. In some cases a thin
fibrous capsule surrounded the aerogel implant and was interpreted as a normal response to foreign material. No
noticeable toxicity was found in the tissues surrounding the implants nor in distant organs. Comparison was made with
control rats without any implants inserted, and animals with suture material present. No obvious or noticeable changes
were sustained by the implants at either location. Careful necropsy and tissue histology showed age-related changes only.
An effective sterilization technique for PCSA implants as well as staining and sectioning protocol has been established.
These studies further support the notion that silica-based aerogels could be useful as biomaterials.
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making them unsuitable for drug delivery and protein loading
applications where the physical size of the entities of interest are on
the order of 10 s of nanometers rather than microns [9,10].
Studies have also shown that cellular uptake of drugs is more
efficient at the nm scale level [11] emphasizing the need for nmscale porous materials and membranes as ideal tools for drug
delivery. The cell size of porous biomaterials also plays an
important role in the formation of scar tissue and fibrosis where
major effort is invested to minimize these formations. There is
evidence to suggest that closely spaced nanometer-sized pores
prevent formation of extensive fibrous connective and scar tissue
and in fact promotes superior tissue integration [12,13].
Additionally, from a mechanical behavior point of view stress

Introduction
Porous biocompatible materials have received particular attention in recent years for a broad range of applications. From filters
and prostheses to scaffolds for tissue engineering, porous
biomaterials have been under constant development and improvement for biological and biomedical applications
[1,2,3,4,5,6,7]. Complications such as poor mechanical performances, batch-to-batch purity variations, and large pore sizes (mm
–range) have limited the extent of use of naturally occurring
biomaterials [8] even though they most closely simulate the native
cellular environment.
Large pore sizes restrict the use of this class of porous materials
to whole cell penetration and tissue infiltration applications only,
PLOS ONE | www.plosone.org
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concentration greatly depends on pore size and is proven to be
significantly less for materials with smaller pore diameters such as
mesoporous materials (pore diameter,50 nm) [14,15].
Aerogels are nanostructured, open-mesoporous (pore diameter,50 nm) ultra low-density lightweight materials with a high
surface-to-volume ratio [16] and tunable surface and bulk
properties allowing for control over potentially key parameters
such as surface wettability, density, opacity, pore size and shape to
name a few [17]. Of particular interest to biological applications
are the polyurea crosslinked silica aerogels (PCSA) where
significant mechanical strength has been accomplished by covalent
crosslinking of the skeletal nanoparticles with polyurea without
significant compromise of the porosity and the low bulk density of
the native material [18,19]. The biocompatibility of silica particles
has been widely explored and has shown a great deal of promise
and compatibility with living matter [20,21,22,23]. Drug delivery
by porous silica has also been explored and offers great promise
[24,25]. At the cellular level, recent in vitro studies on PCSA has
shown good biocompatibility of this material [26,27,28] and the
ability to manipulate the growth of neurons on the PCSA surface
with the aid of a laminin layer [26].
The versatility of sol-gel method for material preparation allows
for doping and pigmenting techniques to be incorporated at the
synthesis stage of aerogels with relative ease [29,30]. Previous
investigations of pigmenting PCSA demonstrated a stable and
non-leaching chemistry while also strengthening the mechanically
properties and retaining the porosity of the aerogels [31]. This can
be of significant interest for biomedical applications since the
majority of polymeric implants used today are translucent or
transparent. Post-surgical identification of a colored implant may
be easier.
In this work, we report the first in vivo assessment of the
biocompatibility of both clear and pigmented PCSA implants in a
rat model sterilized following an ethylene oxide (EtO) sterilization
protocol. The presence of the implants did not result in any
morbidity. In addition, histological evaluation of the tissues
surrounding the implants as well as distant organ sites did not
demonstrate inflammation or substantial tissue damage. The
results of the PCSA implant study were compared to three control
groups: 1) Suture material present (peripheral nerve transection
followed by suture repair), 2) sham surgery, and 3) no surgery.
Results presented in this study demonstrate the biocompatibility of
PCSA thereby supporting the notion that these materials could be
useful for biomedical applications.

Surgical procedure(s)
All surgical procedures were performed on male or female
Sprague-Dawley rats weighing 200–300 gr. Rats were anesthetized 15 min prior to surgery via an initial intramuscular injection
of Telazol (0.03–0.05 ml at 0.3–0.5 mg/kg), followed by isoflurane
inhalation at 1–2%. During the post-surgery recovery period
animals were not restrained and were allowed to continue with
their normal grooming routine. They were fed a routine diet and
kept under close observation for signs of infection or abnormal
behavior. Rats were euthanized post implant recovery by an
overdose of carbon dioxide. This study was approved by the
Animal Care and Use Committee at the University of Memphis.

Surgical group 1: Subcutaneous Implant insertion (n = 4)
An area on the back, approximately 3 cm2, was shaved and a
1 cm incision was made with a scalpel. One pigmented and one
clear implant was inserted subcutaneously in the back of rats (total
of 8 implants). Samples were inserted and immobilized without the
use of any sutures, adhesives, or staples. Figure 1 shows clear
(Figure 1a) and pigmented (Figure 1b) SC PCSA implants after
incubation period, prior to extraction.

Surgical group 2: Intramuscular implant insertion (n = 2)
The left hind limb of rats were abducted and shaved. Under a
dissecting microscope, a transverse incision was made through the
skin of the limb halfway between the iliac crest and the femur’s
articulation with the tibia. A self retracting retainer was replaced,
and dissection was carried down between the biceps femoris and
gluteus muscle until the sciatic nerve was identified. The implant

Materials and Methods
Preparation of clear and pigment-doped aerogels
Pigmented and clear polyurea crosslinked silica aerogels were
synthesized according to our previously described formulation
[30]. The aerogel implants were cut and roughly shaped from the
bulk material using a diamond tipped abrasive disk mounted in a
rotary tool. The samples were then polished by hand to a final size
of 56262 mm3 for the back muscle study and 56262 mm3 for
the deep muscle study. The final stage of implant preparation was
exposure to a small vibratory tumbler containing aluminum oxide
grinding media (approximately 200 mesh), and processed for
about 2 days. The surface contact angle of these aerogels was
measured to be around 45u and a density of 0.4 g/cm3 for clear
and 0.5 g/cm3 for pigmented samples was measured. All implants
were sterilized for 24 hrs by a standard ethylene oxide sterilization
process in an Amprolene system (Anderson Products) prior to
surgery.

PLOS ONE | www.plosone.org

Figure 1. Subcutaneous implant retrieval (surgery site 1).
Optical images of (a) clear and (b) pigmented aerogel implants being
retrieved after twenty months of subcutaneous incubation in SpragueDawley rats. Arrows indicate the embedded implants. A mild fibrosis
can be observed for both pigmented and clear PCSA implants. The
pigmented aerogel samples were much easier to identify compared to
the clear implants.
doi:10.1371/journal.pone.0050686.g001
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to gain weight steadily throughout the implant incubation period
at the same rate as the control groups. At appropriate recovery
time points previous incisions were reopened and the aerogel
implant was identified and removed with a cuff of the surrounding
tissue intact for further analysis. At two weeks, four of the
subcutaneously implanted clear and pigmented PCSA samples
(surgical group 1) were removed for analysis. At twenty months
four more subcutaneously inserted clear and pigmented PCSA
samples (surgical group 1) were removed along with vital organs.
Finally, at seven months time point PCSA implants and vital
organs were removed from surgical group 2. For the sake of
comparison tissue samples from the surgery sites as well as vital
organs were removed from surgical groups 2, 3, and 4 at the same
time point. Post surgery, animals were anesthetized with inhaled
agent and sacrificed at each time point with an overdose of carbon
dioxide. All tissue samples were transferred to jars containing 10%
formaldehyde.

was positioned between the muscle and the sciatic nerve such that
the nerve was in direct contact with the surface of the implant. No
adhesive or sutures were used for immobilizing the aerogel
implant. The skin was then closed with staples and the animal was
then allowed to emerge from anesthesia.

Surgical group 3: Suture repair (n = 2)
The sciatic nerve branches of rats were exposed and transected
sharply as described above. The nerve segments were then
coapted using standard epineural suture technique with interrupted 9-0 nylon.

Surgical group 4: Sham surgery (n = 1)
The sciatic nerve of rats was exposed and severed again sharply,
similar to the method used for suture repair but after severance,
nerve endings were abandoned and no coaptation was attempted.

Implant and tissue retrieval

Histological staining and examination

At time of sacrifice each animal was weighed and its weight
recorded. All animals under investigation in this study continued

Immediately after dissection, tissues containing implants as well
as tissues from distant organs were fixed for at least 18 hrs in 10%
formaldehyde. Tissue segments obtained from organs without
implant were embedded in paraffin and the sections obtained from
these paraffin blocs were stained by hematoxylin eosin (H&E)
following routine procedures.
Initial experiments revealed that adhesion of sectioned PCSA
aerogel implants to glass slides was challenging. Two protocols
were tested to overcome this difficulty. First, implant containing
tissue samples were embedded in polymethylmethacrylate
(PMMA) and the sections obtained from these blocs were mounted
onto plastic slides for staining. This resulted in satisfactory
adhesion of tissue/aerogel samples onto the slides but the
refractive index of the plastic hindered optimal light microscopy
observations. In the second protocol, the implant containing tissue
sections were embedded in paraffin following standard procedures.
Sections of 5 mm thickness were obtained from the paraffin blocks
and various functionalized glass slide surfaces were tested with
respect to their ability to bind the implant present in the tissue
sections. Slides coated with silane (Electron Microscopy Sciences),
poly-L-lysine (Electron Microscopy Sciences), or super-frost
coating (Thermo Fisher Scientific) were unsatisfactory as the
aerogel implants detached readily early during the staining
process. In contrast, the PCSA implant material adhered through
the whole staining and mounting procedure on glass slides coated
Table 1. Summary of short and long term effect of
subcutaneous aerogel implant on local tissue.

Incubation Period
Response

Figure 2. Stain uptake by PCSA sections. H&E stain uptake by
5 mm thick sections of (a) clear and (b) pigmented aerogel samples. The
out-of-focus regions of the image (indicated by arrows) reflect the three
dimensional nature of the aerogel material. While the pores cannot be
visualized by a light microscope, the darker regions are interpreted as
openings to the three dimensional porous structure. Images were taken
with an upright Nikon Eclipse 800 microscope. Striations noticed in (a)
are attributed to sectioning artifacts.
doi:10.1371/journal.pone.0050686.g002

PLOS ONE | www.plosone.org

Two weeks

Twenty months

Clear

Pigmented

Clear

Pigmented

Inflammation

Mild

Mild

Mild

Mild

Fibrosis

Mild

Mild

Mild

Mild

Infection

None

None

None

None

Implant travel

None

None

None

None

Age of rat at time of
extraction

,3 months

,2 years

Slides from both control and implant-containing rats were reviewed blindly by
pathologist, specifically looking for signs of inflammation, infection, fibrosis,
and implant travel.
doi:10.1371/journal.pone.0050686.t001
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Table 2. Summary of the effect of intramuscular aerogel implant on local tissue.

Seven month period
Procedure
Response

Sham

Suture

Implant-clear

Implant-pigmented

Inflammation

Mild

Mild

Mild

Mild

Fibrosis

Mild

Mild

Mild

Mild

Infection

None

None

None

None

Age of rat at time of extraction

9–10 months old

Slides from both control and implant-containing rats were reviewed blindly by pathologist, specifically looking for signs of inflammation, infection, and fibrosis.
doi:10.1371/journal.pone.0050686.t002

Prolonged (.24 hrs and ,30 days) and 3) Permanent (.30 days)
[32]. Aerogel-based biomaterials are expected to serve under
classifications 2 and 3 and incubation periods were chosen
accordingly
Both clear and pigmented PCSA samples were implanted a)
subcutaneously (SC) at the dorsum and b) intramuscularly (IM)
between the gluteus maximus and biceps femoris of the left hind
extremity in Sprague–Dawley rats. Subcutaneous implants were
removed at two weeks and twenty month time points while IM
implants were extracted after seven months of incubation.

with egg albumin (Newcomers Supply). Sections containing the
implant were stained with H&E. Double blinded tissue section
evaluations were performed by a pathologist who, in the case of
sections without implants, was unaware of whether or not the
tissue examined was obtained from an animal with or without
implants. Figure 2 shows the effect of the staining protocol on the
clear (Figure 2a) and pigmented (Figure 2b) control PCSA sections.
It can be seen that the PCSA alone does uptake the stain to a
certain extent. Striations seen in the image are considered to be
staining artifacts and do not reflect PCSA surface morphology. At
times, sectioning the paraffin-embedded tissue-implant samples
was difficult due to the hardness of the PCSA implant and several
attempts had to be made in order to create a uniform section.

Implant Condition
The physical appearance and size of the recovered implants was
not altered as a result of short or long term in vivo incubation.
Macroscopic and microscopic (optical) evaluation of implants
showed no signs of erosion, surface deterioration, or fragmenting.
Additionally, the implants inserted at the different locations did
not appear to have traveled from their original location even
though no immobilization (sutures, adhesives, etc) was used. This

Results and Discussion
Implant incubation times were chosen based on the three
contact duration categories that biomaterials and medical devices
are recommended for testing namely 1) Limited (,24 hrs), 2)

Figure 3. Histological evaluation of the short-term effect of subcutaneous PCSA implants on nearby tissue. Histology of pigmented
aerogel implant extracted after two weeks and stained with methylene blue/basic fucshin. (a) All of the aerogel implant at X 2 magnification, (b) X 20
magnification for spot 1, (c) X 20 magnification of spot 2 and (d) X 10 magnifications of spot 3. A mild fibrosis is observed but no inflammation.
Images were taken with an Olympus BX51 microscope.
doi:10.1371/journal.pone.0050686.g003

PLOS ONE | www.plosone.org
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Figure 4. Histological evaluation of the long-term effect of
subcutaneous PCSA implants on nearby tissue. Histology of (a)
clear and (b) pigmented aerogel implant extracted after seventeen
months of subcutaneous incubation in Sprague-Dawley rats and
stained with H&E. A mild fibrosis is observed but no inflammation.
The dotted line outlines the boundary between PCSA and nearby tissue.
doi:10.1371/journal.pone.0050686.g004

Figure 5. High magnification images of aerogel-muscle interface, intramuscular implantation. Histology of (a) clear and (b)
pigmented aerogel implants extracted after seven months of IM
incubation. At the interface between aerogel and muscle a mild fibrosis
is observed but no inflammation. Darker regions seen on the aerogel
side are associated with the three dimensional, no-planar structure of
aerogel. Images were taken with a Nikon Eclipse 800 microscope.
doi:10.1371/journal.pone.0050686.g005

is particularly surprising in the case of the implants inserted in the
hind leg, since the animal had continuous motion and grooming
ability and its motion was not restricted during the recovery
period. We attribute this to the low density and light weight nature
of the aerogel implant. It is likely that the nanoporous/mesoporous
and three dimensional nature of the surface of the aerogel implants
created anchoring sites between the nearby tissue and the surface
of the PCSA implant.

tion is expected for all foreign materials including biomaterials and
is recognized as part of the body’s foreign body response [34]. The
response seen in this study to the PCSA implants is identified as a
normal reaction.

Fibrosis
In general, the biocompatibility of novel biomaterials with tissue
is evaluated based on the in vivo inflammatory responses as well as
the fibrosis formed around the implant [35]. Fibrous capsule
formation is a well-established reaction to implanted biomaterials
and is recognized as the end stage of the foreign body reaction
[34]. In this study a mild fibrosis and capsule formation was
observed for almost all of aerogel implant-tissue interfaces. Figure 3
shows the SC PCSA-tissue interface behavior for a pigmented
sample. In Figure 3a the whole implant is imaged while Figures 3b,
3c, and 3d show high magnification images of interface and the
fibrous layer formed around the implant for spots 1, 2, and 3
respectively as identified on the image (Figure 3a).
In Figure 4 example cross sectional images of the SC implant
insertion after twenty months of incubation are shown for both
clear (Figure 4a) and pigmented (Figure 4b) PCSA samples. The
dotted line in each case outlines the boundary between the aerogel

Inflammation
In general, irritation and inflammation of the tissue that is in
direct contact with implants is a concern [33]. In this case
however, no significant inflammation was observed for any of the
time points, at the interface of the aerogel implants and the nearby
tissue for both SC and IM surgery types. The amount of
inflammation (according to pathologists report) was categorized
as mild in all cases such that the amount of inflammation observed
for PCSA implants was comparable to the amount of inflammation observed for biocompatible materials particularly surgical
steel and nylon sutures (Tables 1 and 2). This is likely due to the
nanoporous/mesoporous nature of the aerogel implant surface
that while it is highly non-uniform at the nanometer scale, to the
large muscle cells nearby it presents itself smooth and as a result
causes minimum irritation and inflammation. A mild inflammaPLOS ONE | www.plosone.org
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Table 3. Summary of long term effect of intramuscular and subcutaneous aerogel implants on organs.

Procedure
Organ

Sham surgery

Suture surgery

Control (no surgery)

Pigmented/clear aerogel
implant-SC

Pigmented/clear aerogel
implant-IM

Spleen

Unremarkable

Unremarkable

Unremarkable

Undistinguishable

Undistinguishable

Lung

Unremarkable

Unremarkable

Unremarkable

Undistinguishable

Undistinguishable

Heart

Unremarkable

Unremarkable

Unremarkable

Undistinguishable

Undistinguishable

Kidney

Unremarkable

Unremarkable

Unremarkable

Undistinguishable

Undistinguishable

Intestine

Unremarkable

Unremarkable

Unremarkable

NA

NA

doi:10.1371/journal.pone.0050686.t003

and the nearby tissue. Some staining of the PCSA section can be
seen in each case. The thickness of the fibrous layer for the SC
surgery, around the clear and pigmented aerogel implants between
two weeks (Figure 3) and twenty months (sample images shown in
Figure 4) time points did not show a significant difference. In all
cases native cellular tissue had grown up to the implant surfaces. It
is not clear from the tests performed here if any tissue had grown
into the aerogel pores and interstices. From the histological
evaluations it was concluded that the fibrosis around the
pigmented implants wasn’t significantly greater than fibrosis
around clear implants. Table 1 summarizes these results.
Next, the fibrous layer formed around biocompatible materials
such as surgical sutures and surgical tools (images not shown) were
compared with the fibrous layer formed around PCSA implants
inserted intramuscularly. High magnification images of the
interface of clear (Figure 5a) and pigmented (Figure 5b) PCSA
with nearby tissue extracted after seven months of IM incubation
was studied and results are summarized in Table 2. Fibrosis
observed in all cases was classified as ‘‘mild’’ and was in agreement
with the amount of fibrosis observed at the surgery site for suture
and sham surgery procedures. Again, cellular tissue had grown at
least up to the implant and perhaps growth has also occurred into
the structure of the aerogels although, no specific tests were
performed to confirm this.

Summary and Conclusion
This study involves the utilization of in vivo tests to determine the
general biocompatibility of PCSA as a biomaterial. Double
blinded reviews by pathologists showed no statistical difference
between tissue samples collected from different surgical groups
suggesting tolerance and biocompatibility of PCSA. Early in vivo
assessment of tissue compatibility presented here can be used to
influence the design criteria of future PCSA-based medical
devices.
Ethylene oxide sterilization has proven to be an effective
method for sterilizing aerogel implants. The in vivo studies
performed here on a small group of Sprague-Dawley rats have
demonstrated biocompatibility of polyurea crosslinked silica
aerogels over a maximum of twenty month incubation period.
Fibrosis observed was at the normal level that would be observed
with any foreign object including sutures. Although this work was
performed on a small group of animals, it provides the basis for
continuation of the study on a larger group of animals and shows
promise for PCSA as a biomaterial. The nanometer scale
roughness of the aerogel surface seems to play a significant role
in the limited range of motion and travel of the implant from the
surgery site therefore, eliminating the need for sutures. The results
of our in vivo experiments suggest the need for further careful study
to better understand the fundamental processes involved in the
interaction between this specific type of material and the living
body.

Infection
No infection was observed in any of the implant or control
conditions, at any of the time points, suggesting that ethylene oxide
sterilisation is an effective method for sterilising PCSA implants.
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